Regulation of ATP13A2 via PHD2-HIF1α Signaling Is Critical for Cellular Iron Homeostasis: Implications for Parkinson's Disease
about
Anti-Inflammatory and Neuroprotective Role of Natural Product Securinine in Activated Glial Cells: Implications for Parkinson's Disease.Targeting iron metabolism in drug discovery and deliveryExcessive early-life dietary exposure: a potential source of elevated brain iron and a risk factor for Parkinson's disease.Bioactive Flavonoids and Catechols as Hif1 and Nrf2 Protein Stabilizers - Implications for Parkinson's Disease.A novel iron (II) preferring dopamine agonist chelator D-607 significantly suppresses α-syn- and MPTP-induced toxicities in vivo.Hsp90 Co-chaperone p23 contributes to dopaminergic mitochondrial stress via stabilization of PHD2: Implications for Parkinson's disease.
P2860
Regulation of ATP13A2 via PHD2-HIF1α Signaling Is Critical for Cellular Iron Homeostasis: Implications for Parkinson's Disease
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
name
Regulation of ATP13A2 via PHD2 ...... ations for Parkinson's Disease
@ast
Regulation of ATP13A2 via PHD2 ...... ations for Parkinson's Disease
@en
Regulation of ATP13A2 via PHD2 ...... ations for Parkinson's Disease
@nl
type
label
Regulation of ATP13A2 via PHD2 ...... ations for Parkinson's Disease
@ast
Regulation of ATP13A2 via PHD2 ...... ations for Parkinson's Disease
@en
Regulation of ATP13A2 via PHD2 ...... ations for Parkinson's Disease
@nl
prefLabel
Regulation of ATP13A2 via PHD2 ...... ations for Parkinson's Disease
@ast
Regulation of ATP13A2 via PHD2 ...... ations for Parkinson's Disease
@en
Regulation of ATP13A2 via PHD2 ...... ations for Parkinson's Disease
@nl
P2093
P921
P1476
Regulation of ATP13A2 via PHD2 ...... ations for Parkinson's Disease
@en
P2093
Anand Rane
Shankar J Chinta
Subramanian Rajagopalan
P304
P356
10.1523/JNEUROSCI.3117-15.2016
P407
P577
2016-01-01T00:00:00Z